Headline
The latest stories from AHA Today.
The Oklahoma Health Care Authority asked the Centers for Medicare & Medicaid Services to approve a Healthy Adult Opportunity demonstration waiver for its new low-income adult Medicaid population.
The Food and Drug Administration recently announced that Avet Pharmaceuticals Inc. issued a voluntary recall of the antibiotic, tetracycline, specifically, Tetracycline HCl Capsules USP, 250 mg and 500 mg, distributed under the Heritage Pharmaceuticals Inc. label.
The U.S. Customs and Border Protection has launched a webpage to address questions about importing personal protective equipment and other medical products during the COVID-19 pandemic.
The COVID-19 pandemic has created stresses that most health care workers have never experienced, writes Robert Trestman, M.D., of Carilion Clinic in Roanoke, Va., and 2020 chair-elect of AHA’s Behavioral Health Council. Read more about the resources available for front-line workers.
In this AHA blog, Priya Bathija, AHA vice president of strategic initiatives, shares stories of health care heroes stepping up to address the challenge of COVID-19 and ways the public can support them.
In this AHA blog, Priya Bathija, AHA vice president of strategic initiatives, shares stories of health care heroes stepping up to address the challenge of COVID-19 and ways the public can support them.
The Centers for Medicare & Medicaid Services unveiled a new COVID-19 toolkit for state and local health care decision makers seeking to maximize workforce flexibilities.
In response to frequently asked questions, the Centers for Medicare & Medicaid Services encouraged health insurers to relax otherwise applicable utilization management processes, as permitted by state law, to ensure that staff at hospitals, clinics and pharmacies can focus their limited time…
The Health Resources and Services Administration Federal Office of Rural Health Policy today awarded $161.5 million in Coronavirus Aid, Relief and Economic Security Act funding to help rural hospitals and communities respond to the COVID-19 emergency.
Battelle is adding nine processing sites for decontaminating compatible N95 and equivalent respirators for reuse by health care personnel, bringing the total states served to 15 and Washington, D.C.